The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
649
SYNERGISTIC REDUCTION OF INFLAMMATORY CYTOKINES WITH OBEFAZIMOD AND ETRASIMOD IN COMBINATION TREATMENT VS. EITHER MONOTHERAPY IN A MOUSE MODEL OF INFLAMMATORY BOWEL DISEASE
Date
May 5, 2025
Explore related products in the following collection:
